Pharma Forecast: Cloudy But A Hint Of Sun
This article was originally published in The Pink Sheet Daily
IMS' global pharma forecast points to slow 4 percent to 6 percent growth in 2010, although the outlook is brighter than previously anticipated.
You may also be interested in...
HONG KONG - A recent report by Chinese firm Wicon International suggests revenues from pharmaceutical products in China this year could grow by $12 billion to $82 billion. Total sales in 2008 amounted to about $70 billion
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.